Aflibercept in Europe: Setting New Standards in Retinal Disease Care
September 9, 2015
Strength and durability in the real world
1 min read
False
Advertisement
Light Years Ahead
September 9, 2015
What if there was an imaging technique that could detect retinal disease processes before any structural damage had even occurred?
1 min read
Interleukin Forward to a Promising Future in AMD
September 8, 2015
A novel signaling pathway that leads to choroidal neovascularization has been identified – with obvious therapeutic potential
1 min read
First, Do No Harm
September 8, 2015
A new study concludes that most surgical procedures used to treat optic disc pits are of no benefit – and may even be harmful
1 min read
The Poor Man’s Aflibercept?
September 8, 2015
Like bevacizumab before it, ophthalmologists are trying off-label ziv-aflibercept (formulated for systemic use) in the eye. Masterstroke or madness?
1 min read
From Intestine to Eye
September 7, 2015
Gut microbes may be responsible for activating the T-cells that cause autoimmune uveitis
1 min read
New Kid on the Block
September 7, 2015
Can amniotic stem cells suppress pathologic retinal neovascularization?
1 min read
Exploring Ophthalmology’s Orchard
September 7, 2015
Across medicine, far fewer clinical trials report positive results these days. Whether the demise of sharp scientific practices or the lack of low-hanging fruit – does it apply to ophthalmology?
1 min read
Analyzing the AMD Proteome
September 7, 2015
Looking at vitreous samples allows us to determine which proteins are involved in the disease process, and to what degree
1 min read
Taking the Heat out of Retinal Laser Therapy
September 7, 2015
There’s currently an unmet need for effective interventions in early-stage retinal degenerative diseases – before vision is lost. Can three-nanosecond pulse laser therapy meet that need?
1 min read
A Novel Avastin Injection Technique
September 7, 2015
Direct visualization delivery of bevacizumab in pseudophakic eyes for the treatment of subretinal neovascularization
1 min read
AMD – The Modern Marathon
September 7, 2015
The path to truly effective AMD therapies is long and requires us to recognize that it’s not a single disease entity: toil and teamwork are needed to triumph
1 min read
The Long and Winding Road to VEGF
September 7, 2015
Sitting Down With...Patricia A. D’Amore, Director, Howe Laboratory; Director of Research, Schepens EyeResearch Institute, and Charles L. Schepens Professor of Ophthalmology, Harvard Medical School, Massachusetts, USA.
1 min read
Browse by Subspecialties
False
Advertisement